GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viet Nam Pharmaceutical Corp - JSC (HSTC:DVN) » Definitions » EBIT

Viet Nam Pharmaceutical - JSC (HSTC:DVN) EBIT : ₫ Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Viet Nam Pharmaceutical - JSC EBIT?

Viet Nam Pharmaceutical - JSC's earnings before interest and taxes (EBIT) for the six months ended in . 20 was ₫0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


Viet Nam Pharmaceutical - JSC EBIT Historical Data

The historical data trend for Viet Nam Pharmaceutical - JSC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viet Nam Pharmaceutical - JSC EBIT Chart

Viet Nam Pharmaceutical - JSC Annual Data
Trend
EBIT

Viet Nam Pharmaceutical - JSC Semi-Annual Data
EBIT

Competitive Comparison of Viet Nam Pharmaceutical - JSC's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Viet Nam Pharmaceutical - JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viet Nam Pharmaceutical - JSC's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viet Nam Pharmaceutical - JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Viet Nam Pharmaceutical - JSC's EV-to-EBIT falls into.



Viet Nam Pharmaceutical - JSC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was ₫ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viet Nam Pharmaceutical - JSC  (HSTC:DVN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Viet Nam Pharmaceutical - JSC's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

Viet Nam Pharmaceutical - JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Viet Nam Pharmaceutical - JSC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viet Nam Pharmaceutical - JSC EBIT Related Terms

Thank you for viewing the detailed overview of Viet Nam Pharmaceutical - JSC's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Viet Nam Pharmaceutical - JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12 Ngo Tat To, Van Mieu Ward, Dong Da District, Hanoi, VNM
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.